Corrections
Prices and policies in this market change constantly, and sometimes we simply get something wrong. When that happens, we fix it and say so here, newest first.
How we handle a mistake
When you or anyone else tells us something is wrong, we check it against the original source: the company’s own website for anything about a provider, and the study or FDA label for anything medical. If we were wrong, we fix the page and update its date.
Small fixes, like a typo or a broken link, are just fixed. Anything that changes what a reader would take away (a price, a disclosure, a safety fact, or something we said about a company) also gets an entry below, with the month it was made. We don’t quietly rewrite history: an entry stays here even after the page moves on.
Found something? Email ask@semawise.com with the page and the sentence. The rules we write to are in our editorial policy.
Corrections log
Prices mentioned below are what each company showed at the time of the correction. For today’s price, open the current review.
Bodybuilding Health+: $179 is the monthly price, not a first-month deal
We had described $179 as a first-month price, with $279 as the regular rate. The company’s own savings figures are all calculated from $179, which makes it the standing month-to-month price for semaglutide. We corrected that, and updated the multi-month semaglutide and tirzepatide prices to what the company listed at the time.
Read the current review: Bodybuilding Health+
MEDGm: our disclosure said we were not paid, and that stopped being true
The MEDGm review said we had no commercial relationship with the company. When MEDGm became a partner, that sentence became false, so we rewrote the disclosure the same day. Nothing else in the review changed.
Read the current review: MEDGm
LegitScript seals: we overstated what a seal check shows
A few reviews called a provider’s LegitScript seal “independently verified” or “genuine” because its seal number worked. A working seal number only shows that the number was issued, not which website it was issued to. We removed the “verified” language. Plain statements that a company displays a LegitScript certification remain.
He & She MD: the company does name its clinical provider
We said He & She MD published no legal entity. Its FAQ does name the medical practice behind the service and a medical director; only the storefront’s own company name is unpublished. We corrected that, and added something more useful we had missed: the same FAQ says one of its two pharmacies is not licensed in ten states and cannot dispense sterile compounds, which matters for injectable GLP-1s.
Read the current review: He & She MD
Peter MD, Sprout and Eden do name their pharmacies
We said these programs did not name the pharmacy that fills prescriptions. Each one does, in its own terms or about page, and the reviews now say which. We also removed a “503A pharmacy” label from Sprout, because Sprout does not state that itself.
Oak: removed two figures that were discounts, not monthly prices
We listed Oak “from $119 a month” for semaglutide and “from $185” for tirzepatide. On Oak’s own site those figures appear only next to a new-patient discount on a package, not as a monthly rate, and its other published starting prices disagree with each other. We removed both figures. The review now says Oak’s price is not clear without completing its intake.
Read the current review: Oak
FDA warning letters now shown on every page that lists a provider
Some providers that have received an FDA warning letter did not have it mentioned on every page where they appear, and three (Curex, Eden and Hims) were not mentioned at all. Every list, comparison and review now shows the letter, whether or not the provider pays us.
Read the current review: Curex, Eden, Hims, Strut, Sprout, Direct Meds, Zealthy
Bodybuilding Health+: the $139 price was semaglutide, not tirzepatide
We said tirzepatide dropped to $139 a month on a 12-month plan. That $139 was the semaglutide 12-month price; at the time, every multi-month tirzepatide plan actually cost more per month than paying monthly. We corrected the tirzepatide prices and confirmed the semaglutide ones were right.
Read the current review: Bodybuilding Health+
NovoCare: Wegovy's direct self-pay price was out of date
Several articles and our Wegovy cost calculator used about $499 a month for Wegovy bought directly from Novo Nordisk’s NovoCare pharmacy. NovoCare then listed $199 a month for a new patient’s first two fills and $349 a month after that ($399 for the 7.2 mg pen), and $149 a month for the Wegovy pill. We corrected the articles, their tables and FAQs, and the calculator, and the calculator now dates each price separately instead of giving one date for all of them.
Trimi and Direct Meds: both prices had changed
The pages we had used for both companies no longer worked, and when we found their current sites, both prices had moved. Trimi was then $99 a month for semaglutide and $125 for tirzepatide, on annual plans only. Direct Meds was $249 a month for sublingual semaglutide, $297 for injections and $399 for tirzepatide. Both reviews were updated.
Read the current review: Trimi, Direct Meds
Cheapest list: sorted on the price you keep paying
Our cheapest semaglutide list was sorted on each provider’s headline price, which is sometimes a first-month offer. It now sorts on the ongoing price where the company publishes one, and shows which price each provider was sorted on.
How we make money: we described our commissions incorrectly
Our disclosure page and several other pages said commissions never affected which providers we feature. That was wrong. We rewrote how Semawise makes money and every page that repeated the error to say so plainly.
Two guides: citation and sourcing fixes
We corrected the author names on the OASIS 4 trial citation in our oral Wegovy guide, and removed a dose figure from a comparison table in our Rybelsus guide because that article did not cite a source for it.